Webinar: EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine
Creative Biolabs has invited Dr. Magnus A.G. Hoffmann to walk us through the application of hybrid mRNA technology in vaccine development, strategies for optimizing hybrid mRNA vaccines, and the use of this technology in developing pan-coronavirus vaccines.
November 20th, 2024, 2 PM–3 PM EST
Register now to secure your spot: Creative Biolabs Webinar Registration.
Our Services
Precipitation Reagent-Based Separation
We offer precipitation reagent-based exosome separation solutions that are simple to use and highly effective. This method is ideal for labs looking for a quick and reliable way to isolate exosomes from various biological samples.